TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998
TCL Archive NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts July 1, 1983
TCL Archive Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says August 19, 1994
TCL Archive New NCI Grant Program Will Support Young Scientists In Innovative, “Risky” Research May 27, 1977
TCL Archive Mammography For Women Under 50 Debated; Cut Of 3-4% Offered As Budget Trimmer July 23, 1976
